Miroculus Inc.

Miroculus has developed a novel digital microfluidics technology to automate protocols such as sample preparation for next generation sequencing and proteomics, synthetic biology and chemical synthesis, in a compact, user-friendly system. By putting intuitive tools in the hands of people everywhere, we can advance science and improve lives faster, together.

Contact person: Alejandro Tocigl

Job title: CEO